Shafer Michael D 4

4 · THERMO FISHER SCIENTIFIC INC. · Filed Feb 27, 2026

AI-generated summary of this filing

Updated Feb 27, 2026

Thermo Fisher (TMO) EVP Michael Shafer Receives Equity Award

What Happened

Michael D. Shafer, Executive Vice President of Thermo Fisher Scientific (TMO), received equity awards reported on a Form 4 covering transactions on 2026-02-25. The filing shows three award entries totaling 18,396 shares: 1,569 shares (award), 3,129 shares (award), and 13,698 shares reported as a derivative award. All were reported with an acquisition price of $0.00 (typical for restricted stock units/options granted as compensation).

Key Details

Transaction date(s): February 25, 2026; Form 4 filed February 27, 2026 (timely filing).
Transaction type: A = Award/Grant (RSUs and a derivative award/option-like instrument).
Shares acquired: 1,569; 3,129; and 13,698 (total = 18,396).
Price: $0.00 per share (compensation grant).
Shares owned after transaction: Not specified in the provided excerpt of the filing.
Notable footnotes:
- F1: One award is a performance-based restricted stock unit (granted Feb 19, 2025); the committee certified performance on Feb 25, 2026. One‑third vests Feb 28, 2026 and 2027; final third vests Feb 28, 2028 and is subject to upward/downward adjustment based on relative TSR (measurement period Jan 1, 2025–Dec 31, 2027).
- F2: One entry reflects an adjustment to a prior (Feb 22, 2023) performance-based RSU tranche; the committee certified a 15% reduction for relative TSR, reducing the award by 56 shares.
- F3: The derivative award vests in four equal annual installments beginning Feb 28, 2027 (i.e., it is not fully vested immediately).

Context

These are compensation awards (not open-market purchases or sales) and thus reflect company pay and performance determinations rather than direct insider buying/selling. The derivative award’s vesting schedule and the TSR-based adjustments mean portions of the awards remain subject to future vesting and performance outcomes.

Form 4

Period: 2026-02-25

Executive Vice President

Transactions

Award
Common Stock
[F1][F2]
2026-02-25+1,569→ 20,243.803 total
Award
Common Stock
2026-02-25+3,129→ 23,372.803 total
Award
Stock Option (Right to Buy)
[F3]
2026-02-25+13,698→ 13,698 total
Exercise: $513.68Exp: 2036-02-25→ Common Stock (13,698 underlying)

Footnotes (3)

[F1]Shares represent a performance-based restricted stock unit award granted on February 19, 2025. The Company's Compensation Committee determined on February 25, 2026, that the performance criteria related to this award were satisfied. One-third of the shares vest on February 28, 2026 and 2027. The remaining one-third will vest on February 28, 2028, and is subject to adjustment (positive or negative) for long-term performance which is based on the comparison of the Company's total shareholder return compound annual growth rate ("CAGR") to the total shareholder return CAGR of each of the companies in the peer group, as specified within the award agreement, over the measurement period starting on January 1, 2025, through to December 31, 2027.
[F2]Shares represent an adjustment to the final tranche of a performance-based restricted stock unit award granted on February 22, 2023. On February 25, 2026, the Compensation Committee certified a 15% reduction based on the Company's relative TSR performance over the three-year measurement period, resulting in 56 fewer shares than previously reported.
[F3]The option vests in four equal annual installments beginning on February 28, 2027.

Signature

/s/ Melodie T. Morin, Attorney-in-Fact for Michael D. Shafer|2026-02-27

1 file